RETRACTED: Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity
Open Access
- 1 August 2016
- journal article
- retracted article
- Published by Elsevier in Molecular Therapy
- Vol. 24 (8) , 1456-1469
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1R01NS075260)
- National Natural Science Foundation of China (81501062)
- Shaanxi Normal University
This publication has 59 references indexed in Scilit:
- Transfer of Myelin-Reactive Th17 Cells Impairs Endogenous Remyelination in the Central Nervous System of Cuprizone-Fed MiceThe Journal of Neuroscience, 2015
- Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trialsExperimental Neurology, 2014
- Neural stem cells: ready for therapeutic applications?Molecular and Cellular Therapies, 2014
- IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39Nature Immunology, 2013
- Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the ClinicCNS Drugs, 2013
- Experimental Autoimmune Encephalomyelitis2012
- Pathology of Demyelinating DiseasesAnnual Review of Pathology: Mechanisms of Disease, 2012
- Co-Graft of Allogeneic Immune Regulatory Neural Stem Cells (NPC) and Pancreatic Islets Mediates Tolerance, while Inducing NPC-Derived Tumors in MicePLOS ONE, 2010
- Multiple Sclerosis — The Plaque and Its PathogenesisNew England Journal of Medicine, 2006
- Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic miceBrain, 2005